Increased Exercise Tolerance in G6PD African Variant Mice Driven by Metabolic Adaptations and Erythrophagocytosis
Authors:
- Francesca I. CendaliFCFrancesca I. Cendali
- Abby L. GrierAGAbby L. Grier
- Christina LiskChristina Lisk
- Monika DzieciatkowskaMDMonika Dzieciatkowska
- Zachary HaimanZHZachary Haiman
- Julie A. ReiszJRJulie A. Reisz
- Julie HarralJHJulie Harral
- Daniel StephensonDSDaniel Stephenson
- Ariel M. HayAHAriel M. Hay
- Eric P. WartchowEWEric P. Wartchow
- Paul W. BuehlerPBPaul W. Buehler
- Kirk C. HansenKHKirk C. Hansen
Open Access
- 29 July 2025
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 14 (8) , 927
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common enzymatic disorder, affects over 500 million people worldwide and is often linked to exercise intolerance due to oxidative stress, but its true impact on physical performance remains unclear. This study aimed to evaluate the physiological and metabolic effects of G6PD deficiency on endurance capacity. Using humanized mice carrying the African G6PD variant [V68M; N126D] (hG6PDA−), we show that despite reduced pentose phosphate pathway activity, these mice exhibit a 10.8% increase in treadmill critical speed (CS)—suggesting enhanced endurance capacity. Multi-omics profiling across red blood cells, plasma, skeletal muscle, spleen, kidney, and liver reveals metabolic adaptations, including elevated glycolysis, fatty acid oxidation, and increased mitochondrial activity, alongside heightened oxidative phosphorylation in muscle and accelerated red blood cell turnover in the spleen and liver. These findings indicate that systemic metabolic reprogramming may offset antioxidant deficiencies, potentially conferring a performance advantage. Given that G6PD deficiency affects up to 13% of African Americans and is associated with cardiovascular health disparities, our results challenge conventional exercise restrictions and highlight the need for personalized exercise guidelines for affected individuals.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL161004, R01HL146442, R01HL149714, R01HL148151)
This publication has 85 references indexed in Scilit:
- Isotopomer analyses with the tricarboxylic acid cycle intermediates and exchanging metabolites from the rat kidneyNMR in Biomedicine, 2023
- Metabolic Signatures of Performance in Elite World Tour Professional Male CyclistsSports Medicine, 2023
- Iron in blood cells: Function, relation to disease, and potential for magnetic separationBiotechnology and Bioengineering, 2023
- Hemoglobin: Structure, Function and Allostery2020
- The assembly of succinate dehydrogenase: a key enzyme in bioenergeticsCellular and Molecular Life Sciences, 2019
- High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods2019
- Mitochondrial dysfunction and oxidative stress in metabolic disorders — A step towards mitochondria based therapeutic strategiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Developmental plasticity of red blood cell homeostasisAmerican Journal of Hematology, 2014
- Hemoglobin–ligand binding: Understanding Hb function and allostery on atomic levelBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Protein oxidation and proteolysis during aging and oxidative stressArchives of Biochemistry and Biophysics, 1989